×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 21: Interactions with FDA - Part 1
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- Communications with FDA
- Formal Meetings with FDA
- Time Course of Events in Requesting and Preparing for a Meeting >
- Objectives and Conduct of Specific Meetings with FDA
Have an account?